Georgi Dimitrov Raykov

Mr. Georgi Dimitrov Raykov


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Medicina
Verified
Journal Article
Open access
PDF file
KMKaren Mys
Karen Mys
LVLuke Visscher
Luke Visscher
KKKenneth van Knegsel
Kenneth van Knegsel
DGDominic Gehweiler
Dominic Gehweiler
TPTorsten Pastor
Torsten Pastor
PVPeter Varga
Peter Varga
Background and Objectives: Proximal humerus fractures (PHFs) are common in the elderly, but the treatment results are often poor. A clear understanding of fracture morphology and distribution of cortical bone loss is important for improved surgical decision making, operative considerations, and new implant designs. The aim of this study was to develop a 3D segmentation fracture mapping technique to create a statistical description of the spatial pattern and cortical bone loss of complex PHFs. Materials and Methods: Fifty clinical computed tomography (CT) scans of complex PHFs and their contralateral intact shoulders were collected. In-house software was developed for semi-automated segmentation and fracture line detection and was combined with manual fracture reduction to the contralateral template in a commercial software. A statistical mean model of these cases was built and used to describe probability maps of the fracture lines and cortical fragments. Results: The fracture lines predominantly passed through the surgical neck and between the tuberosities and tendon insertions. The superior aspects of the tuberosities were constant fragments where comminution was less likely. Some fracture lines passed through the bicipital sulcus, but predominantly at its edges and curving around the tuberosities proximally and distally. Conclusions: A comprehensive and systematic approach was developed for processing clinical CT images of complex fractures into fracture morphology and fragment probability maps and applied on PHFs. This information creates an important basis for better understanding of fracture morphology that could be utilized in future studies for surgical training and implant design.

15 August 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
GRGeorgi Dimitrov Raykov
Georgi Dimitrov Raykov
JAJakob Adolf
Jakob Adolf
BHBenedikt Jasper Hochbein
Benedikt Jasper Hochbein
GEGeorgi Enev
Georgi Enev
DTDimitar Tenev
Dimitar Tenev
NDNikolay Dimitrov
Nikolay Dimitrov
Biodegradable magnesium (Mg)-based implants represent a paradigm shift in orthopedic biomaterials, offering temporary mechanical support, inherent osteogenic bioactivity, and elimination of hardware removal surgery. These properties are particularly attractive for sports orthopedic applications, including anterior cruciate ligament (ACL) reconstruction, rotator cuff repair, meniscal fixation, and osteochondral fragment refixation, where young, active patients demand rapid return to function and where permanent metallic hardware poses long-term risks of stress shielding, imaging artifact, and reoperation. Despite extensive preclinical evidence demonstrating that Mg-based interference screws promote fibrocartilaginous enthesis regeneration, attenuate peri-tunnel bone loss, and achieve biomechanical fixation comparable to titanium, no human clinical trial has yet evaluated Mg fixation devices for soft-tissue reconstruction in sports medicine. Meanwhile, clinical fracture fixation data from over 468 patients across multiple trials and a meta-analysis confirm complication rates equivalent to those of titanium. This narrative review synthesizes the current evidence on Mg alloy design, surface engineering strategies, preclinical sports medicine applications, clinical translation in fracture fixation, imaging compatibility, and the remaining barriers to clinical adoption in sports orthopedic surgery. By mapping the translational gap between promising animal data and the absence of clinical sports medicine trials, this review aims to guide future research priorities and accelerate the pathway toward clinical application of Mg-based devices in sports orthopedics.

27 August 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
GRGeorgi Dimitrov Raykov
Georgi Dimitrov Raykov
PPPreslav Penev
Preslav Penev
DGDominic Gehweiler
Dominic Gehweiler
JBJan Barcik
Jan Barcik
Boyko GueorguievBoyko Gueorguiev
Boyko Gueorguiev
TPTorsten Pastor
Torsten Pastor
Total talar replacement (TTR) is a joint-preserving alternative to arthrodesis in end-stage talar collapse. However, excising the talus detaches its anchoring ligaments and capsule, and unconstrained prosthesis constructs are prone to malalignment and dislocation. Moreover, it remains unclear whether the instability and its suture stabilisation vary across foot positions. Therefore, the aim of this study was to quantify the positional, load-dependent stability of an unconstrained TTR and the effect of its suture stabilisation. Five human cadaveric lower legs were imaged by weight-bearing computed tomography (CT) imaging in nine positions under 10 N and 700 N load in the intact condition and then with an unconstrained custom 3D-printed specimen-specific TTR, followed by supplementary transosseous suture stabilisation of the anterior talofibular ligament (ATFL) and deep tibiotalar deltoid in the third condition. In the intact ankle condition, load-induced displacements were minimal and unaffected by foot position, averaging no more than 0.52 mm and 0.62°. The unconstrained TTR exhibited position-dependent load-induced displacements, with talar shift increasing significantly by 2.29 mm in inversion and calcaneofibular distance decreasing significantly by 1.54 mm in eversion compared with the intact ankle condition (p ≤ 0.033). Suture stabilisation significantly decreased talar shift by 1.45 mm in inversion and significantly increased calcaneofibular distance by 1.37 mm in eversion, restoring these load-induced displacements toward the intact ankle condition (p = 0.002). In this human cadaveric weight-bearing CT imaging study, an unconstrained TTR benefited from suture reconstruction of the ATFL and deep tibiotalar deltoid attachments, highlighting the value of evaluating construct stability under load across the range of foot positions rather than in neutral stance alone.

16 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DTDimitar Tenev
Dimitar Tenev
NCNikolay Cherkezov
Nikolay Cherkezov
GEGeorgi Enev
Georgi Enev
GRGeorgi Dimitrov Raykov
Georgi Dimitrov Raykov
NDNikolay Dimitrov
Nikolay Dimitrov
Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and fracture risk. Estrogen deficiency is its principal cause in postmenopausal women, sex steroid deficiency is a common cause in men, and several fracture-preventing drugs act on hormonal pathways, although the most widely prescribed agents, the bisphosphonates and denosumab, do not. This narrative review summarizes the randomized trial evidence for estrogen, selective estrogen receptor modulators, the tissue-selective estrogen complex, tibolone, progestogens, parathyroid hormone receptor agonists, and androgens, and for the iatrogenic hypogonadal states produced by androgen deprivation therapy, aromatase inhibitors, gonadotropin-releasing hormone agonists, and glucocorticoids. PubMed, Embase, and the Cochrane Library were searched to September 2026, with priority given to randomized trials with fracture endpoints. Estrogen reduces vertebral and hip fracture in women recruited without regard to bone mineral density, and the benefit ends when treatment ends. Parathyroid hormone receptor agonists produce the largest early reduction in vertebral fracture of any hormonal agent, and the gain is lost unless an antiresorptive drug follows. Testosterone raises bone mineral density in older men but did not reduce fracture in the one adequately powered randomized trial, in which fracture incidence was higher on treatment than on placebo. Hormonal agents are therefore selected for their extraskeletal profile or to correct a hormonal deficit, alongside rather than in place of bisphosphonates, denosumab, and romosozumab. Implications for fracture liaison, perioperative planning, and implant fixation are discussed, and the open questions are stated as specific comparisons.

10 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DTDimitar Tenev
Dimitar Tenev
NCNikolay Cherkezov
Nikolay Cherkezov
GEGeorgi Enev
Georgi Enev
GRGeorgi Dimitrov Raykov
Georgi Dimitrov Raykov
NDNikolay Dimitrov
Nikolay Dimitrov
Kienböck disease is osteonecrosis of the lunate, and it is usually diagnosed late. In one series, symptoms had lasted a mean of 33 months before evaluation, and almost half of the wrists were Lichtman stage IIIB or worse at the first visit, when the options that preserve the lunate are already limited. This narrative review, written with the Scale for the Assessment of Narrative Review Articles (SANRA) as a checklist, summarises evidence published mainly between 2015 and 2026 with two emphases: the timing of diagnosis and the whole range of treatment. Registry data now give a measured incidence. Negative ulnar variance and capitate morphology carry quantified risk. Magnetic resonance imaging is needed when radiographs are normal, computed tomography upstages a third of radiographically staged wrists, and arthroscopy changes the plan in a substantial minority. Treatment runs from immobilisation, which can be definitive in children and low-demand adults, through joint levelling, capitate shortening, core decompression and revascularisation to limited fusion, proximal row carpectomy, implants and salvage. Comparative studies exist, including five small randomised trials, but their size, design and heterogeneity do not establish a consistently superior strategy at any stage. We relate each option to the stage at diagnosis and specify the studies still needed.

17 November 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
NCNikolay Cherkezov
Nikolay Cherkezov
GEGeorgi Enev
Georgi Enev
GRGeorgi Dimitrov Raykov
Georgi Dimitrov Raykov
NDNikolay Dimitrov
Nikolay Dimitrov
DTDimitar Tenev
Dimitar Tenev
Patients who require an orthopaedic implant after cancer treatment present four linked problems: a bone bed damaged by radiotherapy or chemotherapy, large reconstructions under high mechanical load, a high risk of infection, and hardware that degrades the imaging and radiotherapy planning on which oncologic follow-up depends. This narrative review examines how each problem alters implant performance and which design responses have clinical support. Radiotherapy roughly doubles dental implant failure, is associated with loosening, infection, and periprosthetic fracture after arthroplasty, and leads to non-union in most radiation-associated femoral fractures treated by internal fixation. Deep infection affects about one in ten tumour endoprostheses. Additively manufactured porous titanium and porous tantalum support bone ingrowth, but follow-up rarely exceeds five years, and their large surface area may favour bacterial colonisation. Silver, iodine, and antibiotic-loaded hydrogel coatings are associated with fewer infections in observational studies, with low certainty. Carbon-fibre-reinforced polyetheretherketone (PEEK) reduces imaging artefact and dose perturbation, and biodegradable magnesium avoids hardware removal, but neither has a proven advantage in oncologic reconstruction. Throughout, evidence is labelled by its source—oncologic, extrapolated, or preclinical—and the comparative studies still needed are specified.